Precision Motion Health
Private Company
Total funding raised: $3.2M
Overview
Precision Motion Health is a commercial-stage diagnostics and data intelligence company focused on musculoskeletal health. Its core technology is an FDA-registered Electromyographic Functional Assessment (EFA) system, which it has evolved into a broader AI-powered platform for injury risk prediction, objective assessment, and personalized recovery. Founded in 2012 (originally as Emerge Diagnostics) and rebranded in 2024, PMH reports validated outcomes for large employers, including significant reductions in claim costs and duration, positioning it at the intersection of digital health, diagnostics, and occupational medicine.
Technology Platform
The Soft Tissue Intelligence Platform integrates a patented, FDA-registered Electromyographic Functional Assessment (EFA) – which combines surface EMG, range-of-motion, and force measurement – with AI and machine learning analytics. This platform transforms objective diagnostic data into predictive risk insights and personalized recovery pathways.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
PMH competes in a fragmented market including traditional diagnostic imaging, wearable sensor companies (e.g., dorsaVi, VALD), digital musculoskeletal therapy platforms (e.g., Hinge Health, Sword Health), and broader workplace safety analytics firms. Its key differentiation is the combination of an FDA-registered diagnostic device with AI analytics, targeting the specific workflow and cost-containment needs of the workers' compensation ecosystem.